Unravelling the Mysteries of Multiple Sclerosis, Why Are Women More Vulnerable?

Unravelling the Mysteries of Multiple Sclerosis, Why Are Women More Vulnerable?

Introduction

Multiple sclerosis (MS) is a neurological enigma that affects millions of people globally, yet much about the disease remains shrouded in mystery. Its symptoms can range from mild tingling in the extremities to severe disability, and while there’s no cure, ongoing research is shedding light on why some individuals—and particularly women—are more at risk.

The public became acutely aware of the debilitating nature of MS when actress Christina Applegate revealed her battle with the disease. Known for her sharp wit and humor on-screen, Applegate’s reality off-screen took a dramatic turn when she began experiencing tingling in her toes. This symptom quickly escalated, leading to a diagnosis that would forever change her life. As the disease progressed, she faced increasing physical and emotional challenges, including pain, depression, and difficulty walking.

Applegate’s story is just one of many. Around 2.9 million people worldwide, including approximately one million in the United States, are living with MS. The disease disrupts the central nervous system, attacking the protective myelin sheaths that insulate nerve fibers in the brain and spinal cord. When this insulation deteriorates, it leaves the underlying nerves vulnerable, disrupting the brain’s communication pathways and leading to a wide array of symptoms.

The Complex Symptoms of MS

MS is often categorized into two main types: relapsing-remitting, where symptoms come and go, and progressive, where symptoms worsen over time. However, as neurologist Riley Bove from the University of California, San Francisco, points out, this distinction can be misleading. All patients experience some degree of symptom progression, especially as they age, which complicates the disease’s trajectory. Aging naturally leads to muscle loss and decreased strength, but for those with MS, this process is accelerated.

Common symptoms of MS include numbness, loss of coordination, vision problems, and speech difficulties. However, some of the most challenging symptoms are invisible to others, such as chronic fatigue and bladder dysfunction. These "invisible" symptoms can be particularly isolating, as they are less understood by those without the disease, making it harder for patients to receive the empathy and support they need.

Depression is another common companion to MS, affecting about half of all patients at some point after their diagnosis. While some of this depression may be a natural reaction to the diagnosis, research suggests that the disease itself, particularly the brain damage it causes, plays a significant role.

What Triggers MS? The Role of Epstein-Barr Virus

The exact cause of MS remains elusive, but scientists have identified a strong link between the disease and the Epstein-Barr virus (EBV). A groundbreaking study published in Science in 2022 found that individuals infected with EBV were over 30 times more likely to develop MS. Given that EBV is widespread—infecting about 90% of adults worldwide—this connection has significant implications.

According to Alberto Ascherio, an epidemiologist at the Harvard T.H. Chan School of Public Health, the relationship between EBV and MS is similar to that between smoking and lung cancer. While smoking greatly increases the risk of lung cancer, not all smokers develop the disease. Similarly, while EBV may trigger MS in some individuals, the majority of those infected with the virus will not develop MS.

Why Are Women More at Risk?

One of the most perplexing aspects of MS is its disproportionate impact on women, who are three times more likely than men to be diagnosed with the disease. The reasons for this gender disparity are still unclear, but several theories exist. Some researchers suggest that women’s immune systems are more reactive to foreign DNA due to their reproductive roles, which could make them more susceptible to autoimmune diseases like MS. Others speculate that sex chromosomes or hormonal differences might play a role, though the specifics are still under investigation.

Interestingly, the stereotype that MS primarily affects white women has begun to shift. Recent research indicates that MS occurs across all racial and ethnic groups, but disparities in healthcare access and diagnosis may have skewed earlier perceptions. As Bove notes, awareness is crucial in all communities to ensure early diagnosis and treatment, which can significantly alter the disease’s course.

Looking Ahead, Prevention and Treatment

Currently, there is no cure for MS, and preventive measures are limited. Lifestyle changes such as quitting smoking, maintaining a healthy diet, and ensuring adequate Vitamin D intake can reduce risk, but these are not foolproof strategies.

Researchers are exploring new ways to diagnose and treat MS, including the identification of blood markers for neuroinflammation, which could help predict flare-ups and guide treatment decisions. Vaccines and antiviral drugs targeting EBV are also under investigation, offering hope that one day, the incidence of MS might be significantly reduced.

For now, the focus remains on managing symptoms and preventing further damage. Early diagnosis and treatment are key to improving outcomes, as emphasized by María Gaitán, acting director of the Neuroimmunology Clinic at the National Institute of Neurological Disorders and Stroke. "Awareness and early intervention can change the evolution of the disease," she says.

References

  1. Bove, R., et al. Journal of Neurology, 2023.
  2. Ascherio, A., et al. Science, 2022.
  3. Gaitán, M., et al. The Lancet Neurology, 2021.
  4. Charvet, L., et al. Multiple Sclerosis Journal, 2024.

 

Back to blog